{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:19:45Z","timestamp":1777317585156,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ctro.2024.100744","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T12:44:43Z","timestamp":1708001083000},"page":"100744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Stereotactic body radiotherapy of central lung tumours using a 1.5\u00a0T MR-linac: First clinical experiences"],"prefix":"10.1016","volume":"45","author":[{"given":"L.G.","family":"Merckel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pomp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.L.","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L.H.M.W.","family":"van Lier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"van den Dobbelsteen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.A.","family":"Rasing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.A.A.","family":"Mohamed Hoesein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.W.","family":"Snoeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"van Es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.S.N.","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Fast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.C.","family":"Verhoeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2024.100744_b0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.canrad.2006.11.001","article-title":"Stereotactic body radiation therapy (SBRT) for early-stage lung cancer","volume":"11","author":"Hiraoka","year":"2007","journal-title":"Cancer\/radiotherapie"},{"key":"10.1016\/j.ctro.2024.100744_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107284","article-title":"Stereotactic body radiotherapy for lung oligo-metastases: systematic review and international stereotactic radiosurgery society practice guidelines","volume":"182","author":"Mayinger","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctro.2024.100744_b0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.clon.2020.09.008","article-title":"Image-guided radiotherapy to manage respiratory motion: lung and liver","volume":"32","author":"Dhont","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107281","article-title":"Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines","volume":"182","author":"Yan","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctro.2024.100744_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-022-02183-3","article-title":"Dose-effect relationship of stereotactic body radiotherapy in non-small cell lung cancer patients","volume":"17","author":"Li","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0030","article-title":"Multi-institutional outcomes of stereotactic magnetic resonance image guided adaptive radiation therapy with a median biologically effective dose of 100 Gy10 for non-bone oligometastases","volume":"7","author":"Kutuk","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-020-01491-w","article-title":"Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors","volume":"15","author":"Zhao","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41571-022-00631-3","article-title":"Integrated MRI-guided radiotherapy \u2014 opportunities and challenges","volume":"19","author":"Keall","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0045","doi-asserted-by":"crossref","first-page":"689","DOI":"10.21037\/tlcr.2017.09.02","article-title":"Magnetic resonance imaging in precision radiation therapy for lung cancer","volume":"6","author":"Bainbridge","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ctro.2024.100744_b0050","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/mrm.29450","article-title":"The future of MRI in radiation therapy: Challenges and opportunities for the MR community","volume":"88","author":"Goodburn","year":"2022","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.ctro.2024.100744_b0055","doi-asserted-by":"crossref","first-page":"L41","DOI":"10.1088\/1361-6560\/aa9517","article-title":"First patients treated with a 1.5 T MRI-Linac: Clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment","volume":"62","author":"Raaymakers","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2024.100744_b0060","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijrobp.2022.07.027","article-title":"MRI-guided Radiotherapy (MRgRT) for treatment of oligometastases: review of clinical applications and challenges","volume":"114","author":"Chetty","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100744_b0065","first-page":"98","article-title":"Technical design and concept of a 0.35 T MR-Linac","volume":"18","author":"Kl\u00fcter","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0070","first-page":"72","article-title":"4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience","volume":"23","author":"Paulson","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0075","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1378\/chest.128.4.2490","article-title":"Clinical prediction model to characterize pulmonary nodules: Validation and added value of18F-fluorodeoxyglucose positron emission tomography","volume":"128","author":"Herder","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ctro.2024.100744_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2021.634507","article-title":"Technical challenges of real-time adaptive MR-guided radiotherapy","volume":"11","author":"Thorwarth","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejmp.2017.04.010","article-title":"Organs at risk in lung SBRT","volume":"44","author":"De Rose","year":"2017","journal-title":"Phys Medica"},{"key":"10.1016\/j.ctro.2024.100744_b0090","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","article-title":"Consideration of dose limits for organs at risk of thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus","volume":"81","author":"Ing","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100744_b0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phro.2018.11.003","article-title":"The effect of density overrides on magnetic resonance-guided radiation therapy planning for lung cancer","volume":"8","author":"Schrenk","year":"2018","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0100","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1002\/mp.13826","article-title":"Investigating the impact of patient arm position in an MR-linac on liver SBRT treatment plans","volume":"46","author":"van den Wollenberg","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.ctro.2024.100744_b0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2019.11.001","article-title":"Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91","volume":"142","author":"de Jong","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijrobp.2013.10.015","article-title":"Alpha\/beta ratio for normal lung tissue as estimated from lung cancer patients treated with stereotactic body and conventionally fractionated radiation therapy","volume":"88","author":"Scheenstra","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100744_b0115","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2007.11.075","article-title":"The radiation dose-response of the human spinal cord","volume":"71","author":"Schultheiss","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100744_b0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.radonc.2019.01.024","article-title":"Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases","volume":"134","author":"Werensteijn-Honingh","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0125","first-page":"54","article-title":"Adaptive radiotherapy: The Elekta Unity MR-linac concept","volume":"18","author":"Winkel","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0130","doi-asserted-by":"crossref","unstructured":"Tekatli H, Palacios MA, Schneiders FL, Haasbeek CJA, Slotman BJ, Lagerwaard FJ, et al. Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy. Radiother Oncol 2023;187. https:\/\/doi.org\/10.1016\/j.radonc.2023.109823.","DOI":"10.1016\/j.radonc.2023.109823"},{"key":"10.1016\/j.ctro.2024.100744_b0135","first-page":"60","article-title":"The rationale for MR-only treatment planning for external radiotherapy","volume":"18","author":"Jonsson","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0140","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1002\/mp.15802","article-title":"A hybrid 2D\/4D-MRI methodology using simultaneous multislice imaging for radiotherapy guidance","volume":"49","author":"Keijnemans","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.ctro.2024.100744_b0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2022.01.009","article-title":"Technical feasibility and clinical evaluation of 4D-MRI guided liver\u20182 SBRT on the MR-linac","volume":"167","author":"van de Lindt","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100744_b0150","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijrobp.2018.09.011","article-title":"Tumor Trailing for Liver SBRT on the MR-Linac","volume":"103","author":"Fast","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2024.100744_b0155","doi-asserted-by":"crossref","unstructured":"Grimbergen G, Hackett SL, van Ommen F, van Lier ALHMW, Borman PTS, Meijers LTC, et al. Gating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors. Radiother Oncol 2023;189:109932. https:\/\/doi.org\/10.1016\/j.radonc.2023.109932.","DOI":"10.1016\/j.radonc.2023.109932"},{"key":"10.1016\/j.ctro.2024.100744_b0160","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/mp.14772","article-title":"Dosimetric evaluation of MRI-guided multi-leaf collimator tracking and trailing for lung stereotactic body radiation therapy","volume":"48","author":"Uijtewaal","year":"2021","journal-title":"Med Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T02:42:21Z","timestamp":1742179341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630824000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"alternative-id":["S2405630824000211"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100744","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic body radiotherapy of central lung tumours using a 1.5\u00a0T MR-linac: First clinical experiences","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100744"}}